COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 1054: Articles 10531-10540  | Next

Timing of exposure is critical in a highly sensitive model of SARS-CoV-2 transmission
Ganti, K., Lowen, A. C., Ferreri, L. M., Lee, C.-Y., Bair, C. R., Delima, G. K., Holmes, K. E., Suthar, M. S.
10.1101/2021.12.08.471873 — Posted: 2021-12-11
Estimates of reduced vaccine effectiveness against hospitalization, infection, transmission and symptomatic disease of a new SARS-CoV-2 variant, Omicron (B.1.1.529), using neutralizing antibody titers
Gardner, B. J., Kilpatrick, A. M.
10.1101/2021.12.10.21267594 — Posted: 2021-12-11
Coronavirus (COVID-19) Spike in Georgia: An Epidemiologic Study of Data, Modelling, and Policy Implications to Understand the Gender-and Race-Specific Variations
Mostafa, F., Ganji, R., St. John, J., Khan, H.
10.1101/2021.12.09.21267571 — Posted: 2021-12-11
Exploring selection bias in COVID-19 research: Simulations and prospective analyses of two UK cohort studies
Millard, L. A. C., Fernandez-Sanles, A., Carter, A. R., Hughes, R., Tilling, K., Morris, T. P., Smith, D., Griffith, G. J., Clayton, G. L., Kawabata, E., Davey Smith, G., Lawlor, D. A., Borges, M. C.
10.1101/2021.12.10.21267363 — Posted: 2021-12-11
Incidence rates and symptomatology of community infections with SARS-CoV-2 in children and parents: The CoKids longitudinal household study
de Hoog, M., Post-Sluiter, J., Westerhof, I., Fouri, E., Heuvelman, V., Boom, T., Euser, S. M., Badoux, P., Reusken, C., Bont, L., Sanders, E., Jaddoe, V., Herpers, B., Eggink, D., Wildenbeest, J., Duijts, L., Houten, M. v.
10.1101/2021.12.10.21267600 — Posted: 2021-12-11
Reduced neutralisation of SARS-COV-2 Omicron-B.1.1.529 variant by post-immunisation serum
Dejnirattisai, W., Shaw, R. H., Supasa, P., Liu, C., Stuart, A. S. V., Pollard, A. J., Liu, X., Lambe, T., Crook, D., Stuart, D. I., Mongkolsapaya, J., Nguyen-Van-Tam, J. S., Snape, M. D., Screaton, G. R., Com-COV2 Study Group
10.1101/2021.12.10.21267534 — Posted: 2021-12-11 Discussion: Onsite
SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals
Roessler, A., Riepler, L., Bante, D., von Laer, D., Kimpel, J.
10.1101/2021.12.08.21267491 — Posted: 2021-12-11
Food for thought: Eating before saliva collection and interference with SARS-CoV-2 detection
Hernandez, M. M., Riollano-Cruz, M., Boyle, M. C., Banu, R., Shrestha, P., Gray, B., Cao, L., Chen, F., Shi, H., Paniz-Perez, D. E., Paniz-Perez, P. A., Rishi, A. L., Dubinsky, J., Dubinsky, D., Dubinsky, O., Baine, S., Baine, L., Arinsburg, S., Baine, I., Ramirez, J. D., Cordon-Cardo, C., Sordillo, E. M., Paniz Mondolfi, A. E.
10.1101/2021.12.09.21267539 — Posted: 2021-12-11
Accuracy and usability of saliva and nasal rapid antigen self-testing for detection of SARS-CoV-2 infection in the general population: a head-to-head comparison
Schuit, E., Venekamp, R. P., Veldhuijzen, I. K., van den Bijllaardt, W., Pas, S. D., Stohr, J. J. J. J. M., Lodder, E. B., Hellwich, M., Molenkamp, R., Igloi, Z., Wijers, C., Vroom, I. H., Nagel-Imming, C. R. S., Han, W. G. H., Kluytmans, J. A. J., van den Hof, S., Van de Wijgert, J. H. H. M., Moons, K. G. M.
10.1101/2021.12.08.21267452 — Posted: 2021-12-11 Discussion: Onsite
Neutralizing Antibody Activity Against SARS-CoV-2 Variants in Gestational Age-Matched Mother-Infant Dyads
Matsui, Y., Li, L., Prahl, M., Cassidy, A. G., Ozarslan, N., Golan, Y., Gonzalez, V. J., Lin, C. Y., Jigmeddagva, U., Chidboy, M. A., Montano, M., Taha, T. Y., Khalid, M. M., Sreekumar, B., Hayashi, J. M., Chen, P.-Y., Kumar, G. R., Warrier, L., Wu, A. H. B., Song, D., Jegatheesan, P., Rai, D. S., Govindaswami, B., Needens, J., Rincon, M., Myatt, L., Asiodu, I. V., Flaherman, V. J., Afshar, Y., Jacoby, V. L., Murtha, A. P., Robinson, J. F., Ott, M., Greene, W. C., Gaw, S. L.
10.1101/2021.12.09.21267557 — Posted: 2021-12-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).